Mar. 31 at 11:10 PM
$BYND I will add one more interesting factoid. Pick a stock, any stock. Take
$ARQQ for instance. Now here is the biggest colossal bag of crap since it showed up via SPAC. It traveled back and forth from
$15 to
$60 at least 3 or 4 times on ZERO sales. NOT a biotech. Then they finally booked annual sales of
$67000. Still hung out
$40-
$50. Bot about a half million in sales and down near the lows at
$12+.
But the kicker? Nobody bothers it. even at 12 it trades at 2700 times sales.
Why ARQQ? The same mkt cap as BYND and BYND trades less than 1 times sales.
